The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo.
Lucas DM, Alinari L, West DA, Davis ME, Edwards RB, Johnson AJ, Blum KA, Hofmeister CC, Freitas MA, Parthun MR, Wang D, Lehman A, Zhang X, Jarjoura D, Kulp SK, Croce CM, Grever MR, Chen CS, Baiocchi RA, Byrd JC.
Lucas DM, et al. Among authors: davis me.
PLoS One. 2010 Jun 3;5(6):e10941. doi: 10.1371/journal.pone.0010941.
PLoS One. 2010.
PMID: 20532179
Free PMC article.